ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2678

UC-MSCs Inhibit T Cell Autophagy and Apoptosis in Patients with Systemic Lupus Erythematosus through Mitochondrial Transfer

Jinyun Chen1, Xuebing Feng2 and Lingyun Sun2, 1The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China, 2Department of Rheumatology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: autophagy, Mesenchymal stem cells and systemic lupus erythematosus (SLE), T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis: T and B Cell Signaling and Genetic Variants

Session Type: Abstract Submissions (ACR)

Background/Purpose This study is aimed to investigate the role of umbilical cord derived mesenchymal stem cells (UC-MSCs) on autophagy and apoptosis in T cells from SLE patients, and to explore the underline mechanisms involved in this process.

Methods Peripheral blood mononuclear cells (PBMC) were isolated from SLE patients and healthy donors, and cultured under stimulation with anti-CD3/28 antibodies in the presence or absence of autophagy inhibitor 3-MA (5mM for 6h) or activator rapamycin (50nM for 48h). Autophagy levels and apoptotic rates were measured by flow cytometry with the detection of LC3IIB and Annexin V respectively. To determine the effects of MSCs on T cell autophagy and apoptosis, UC-MSCs were cocultured with T cells at the ratio of 1:10 directly or in transwell system. To observe the changes of pathways upstream of autophagy after MSC treatment, an AMPK activator was added to the cocultures. Meanwhile, mitochondria transmembrane potential (¦¤¦·m), which was closely related to APPK activation, was marked and measured in MSCs and T cells by MitoTracker Deep Red (MDR).

Results T cells from SLE patients had both elevated autophagy level and apoptotic rate compared with those from normal controls, which were further increased after anti-CD3/CD28 stimulation. Apoptotic rate of T cells significantly correlated with autophagy level (r=0.570, p<0.0001 for CD4+T; r=0.508, p=0.0001 for CD8+T). Inhibition of autophagy with 3-MA decreased the apoptotic rate of T cells, whereas activation of autophagy with rapamycin increased the apoptotic rate. UC-MSCs significantly inhibited T cell autophagy (22.5±2.4 vs. 36.4±6.3 for CD4+T; 27.2±1.9 vs. 39.2±5.4 for CD8+T, both p<0.05) and T cell apoptosis (22.2±2.6% vs. 49.1±5.7 % for CD4+T; 23.3±2.4% vs. 53.2±2.3 % for CD8+T, both p<0.05) after cell-to-cell contact coculturing, yet the effect was diminished in transwell system. When AMPK activator added to the cultures, the ability of UC-MSCs to regulated T cell apoptosis was greatly impaired. As shown in Figure 1, mitochondria in UC-MSCs could be transferred to SLE T cells when directly cocultured. Consequently, the elevation of ¦¤¦·m in T cells was downregulated after MSC treatment (242.5±8.4 vs. 315.8±5.5, p=0.003 for CD4+T; 139.8±23.5 vs. 199±35.7, p=0.06 for CD8+T), along with the reduction of AMPK.

Conclusion Autophagy levels are elevated in T cells from SLE patients, leading to aberrant apoptosis. UC-MSCs may inhibit T cell autophagy and apoptosis through mitochondrial transfer.

Figure 1 Transfer of MSC mitochondria to lupus T cells. Mitochondria in MSCs were marked by MitoTracker Deep Red. After cell-to-cell contact coculture, MSC-derived mitochondria were detectable in T cells.


Disclosure:

J. Chen,
None;

X. Feng,
None;

L. Sun,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/uc-mscs-inhibit-t-cell-autophagy-and-apoptosis-in-patients-with-systemic-lupus-erythematosus-through-mitochondrial-transfer/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology